Hepatitis B, Chronic: all 954 studies

Page 6 of 10. Open to participants first (147), then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B VirusTerminatedNCT04059198Phase 2
• The Clinical Cure Project of Chronic Hepatitis B in ChinaActive, not recruitingNCT04035837Phase 4
• Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV InfectionCompletedNCT04032275
• Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned InterventionStatus unknownNCT04030039
• Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis BCompletedNCT04028856
• Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC InhibitorTerminatedNCT04023721Phase 2
• A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)CompletedNCT04008004Phase 1
• Prediction Model Based on Computed Tomography Liver Volume for the Short-term Mortality in Hepatitis B Related Acute-on-ChronicCompletedNCT03977857
• Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B PatientsTerminatedNCT03932513Phase 2
• Serum HBV RNA Value on Chronic Hepatitis B Virus Infection ManageCompletedNCT03909191
• Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy VolunteersCompletedNCT03847246Not applicable
• A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsStatus unknownNCT03801798Phase 2
• The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAgStatus unknownNCT03801538Phase 4
• Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
• Prediction System of Clinical Endpoint Events for Chronic Hepatitis B PatientsActive, not recruitingNCT03777969
• Study of Safety and Tolerability of DCR HBVSCompletedNCT03772249Phase 1
• A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINAStatus unknownNCT03770624Phase 1
• Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral ActivityStatus unknownNCT03759782Phase 3
• Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current GuidelinesActive, not recruitingNCT03753074Phase 4
• TAF Real World Study for Universal EffectivenessStatus unknownNCT03752658
• Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase LevelsStatus unknownNCT03740789
• IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHBCompletedNCT03734783
• Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT03733652Not applicable
• A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT03714152Phase 1
• The Norwegian Nucleoside Analogue Stop StudyCompletedNCT03681132Phase 4
• A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy SubjectsCompletedNCT03662568Phase 1
• Terminator 2 RegisterStatus unknownNCT03643172
• A Post-marketing Surveillance to Assess Safety and Efficacy of BesivoStatus unknownNCT03642340
• The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate CapsulesCompletedNCT03638076Phase 2
• Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty LiverStatus unknownNCT03604016Phase 4
• Tenofovir Combination or Mono-therapy for MDR CHBStatus unknownNCT03597633
• Study on Gut Microbiota in Chronic HBV Infected PatientsStatus unknownNCT03587467
• APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis BCompletedNCT03585322Phase 1
• Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnNCT03575208Phase 2
• Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral ResistanceStatus unknownNCT03566030
• Treatment Efficacy and Safety of TDF-TAF Switch Study in South KoreaStatus unknownNCT03559790
• The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT03546530Not applicable
• Observational Study on Pregnant Women With Chronic Hepatitis B and Their InfantsStatus unknownNCT03539016
• Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral InfectionsStatus unknownNCT03495570
• Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B PatientsCompletedNCT03485534Phase 4
• Drug Drug Interaction Study for EYP001 With EntecavirCompletedNCT03469583Phase 1
• The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedNCT03468907Phase 4
• A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically SuppressedCompletedNCT03463369Phase 1
• Cohort Study on People Who Inject Drugs in SenegalStatus unknownNCT03459768
• Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced PatientsStatus unknownNCT03448744Phase 4
• A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis BCompletedNCT03439488Phase 1
• Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis BStatus unknownNCT03429439Not applicable
• A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis BCompletedNCT03426618
• Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfectionStatus unknownNCT03425994
• HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAgStatus unknownNCT03405597Phase 3
• Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral TherapyStatus unknownNCT03366571
• A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study)Status unknownNCT03358108
• A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis BStatus unknownNCT03357822Phase 4
• Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDFCompletedNCT03356834Phase 4
• HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue TherapyCompletedNCT03350074
• Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownNCT03349008Phase 4
• Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B PatientsStatus unknownNCT03332329Phase 4
• Quality of Life and Health Utility of Patients With CHB InfectionsCompletedNCT03329820
• EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT03320616Phase 1
• The Effect of Entecavir Consolidation on Post-TDF Treatment DurabilityStatus unknownNCT03308890Phase 4
• Biologic Basis of Liver Cancer From Chronic Hepatitis BCompletedNCT03300414
• Evaluation of the Safety and Pharmacology of EYP001 in HBV SubjectsCompletedNCT03272009Phase 1
• The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by ResectionStatus unknownNCT03253250Phase 4
• A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B PatientsStatus unknownNCT03244085Phase 1
• Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.CompletedNCT03241641Phase 4
• Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus TenofovirStatus unknownNCT03236610Phase 3
• Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus AdefovirStatus unknownNCT03236584Phase 3
• Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, SenegalCompletedNCT03215732
• The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionStatus unknownNCT03214302Not applicable
• The Changes of Cytokines During Antiviral TherapyStatus unknownNCT03210506Not applicable
• The Changes of Treg Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210493Not applicable
• The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03210467
• The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal TimeStatus unknownNCT03209908
• The Changes of CD8+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209037Phase 4
• The Changes of CD4+T Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03209011Phase 4
• The Changes of Natural Killer Cells Frequency and Function During Antiviral TherapyStatus unknownNCT03208998Phase 4
• Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBVCompletedNCT03181607
• Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa TherapyCompletedNCT03181113
• The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03180333Phase 1
• The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult VolunteersCompletedNCT03173599Phase 1
• Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B PatientsTerminatedNCT03164889Not applicable
• A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B SubjectsWithdrawnNCT03125213Phase 2
• To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.Status unknownNCT03123653Not applicable
• Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis BCompletedNCT03109730Phase 1/2
• The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCCStatus unknownNCT03084250Phase 4
• Off-therapy Response After Stopping Entecavir or TenofovirStatus unknownNCT03042481
• Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy VolunteersTerminatedNCT03032536Phase 1
• Study of Hepalatide(L47) at Phase Ib in Healthy VolunteersCompletedNCT03023787Phase 1
• The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis BStatus unknownNCT03018821Not applicable
• Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B PatientsStatus unknownNCT03013556Phase 4
• The HOPE Study: Characterizing Patients With Hepatitis B and CActive, not recruitingNCT02995252
• Peg-interferon for Inactive Chronic Hepatitis B CarriersCompletedNCT02992704Phase 2/3
• Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus CarriersStatus unknownNCT02991638Phase 3
• To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis BStatus unknownNCT02982837Phase 4
• REALM China Extension StudyStatus unknownNCT02974829
• Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor DetectionStatus unknownNCT02973646Phase 4
• Efficacy and Safety of DA-2802 in Chronic Hepatitis B PatientsCompletedNCT02967939Phase 3
• A Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBVStatus unknownNCT02966964Phase 2
• The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis BStatus unknownNCT02965859Phase 2
• Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative ConcentrationStatus unknownNCT02953600Not applicable

← Hepatitis B, Chronic overview